2016
DOI: 10.1016/j.jmmm.2015.10.111
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic manipulation of superparamagnetic nanoparticles in a microfluidic system for drug delivery applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
29
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 71 publications
(29 citation statements)
references
References 22 publications
0
29
0
Order By: Relevance
“…Nowadays, the use of magnetic nanoparticles as drug transporters has been an area of significant interest [5]. Besides its biocompatibility, one reason for using magnetite Fe 3 O 4 nanoparticles in this type of delivery system, is given by the possibility of applying any of the previously mentioned targeting approaches: passive by EPR [6], and active by magnetic targeting [7,8,9,10] or specific functionalizing [11,12,13,14]. Fe 3 O 4 nanoparticles have been already used as carriers for GEM in some in vitro approaches aiming to improve the drug release time [15], and efficiency [16,17].…”
Section: Introductionmentioning
confidence: 99%
“…Nowadays, the use of magnetic nanoparticles as drug transporters has been an area of significant interest [5]. Besides its biocompatibility, one reason for using magnetite Fe 3 O 4 nanoparticles in this type of delivery system, is given by the possibility of applying any of the previously mentioned targeting approaches: passive by EPR [6], and active by magnetic targeting [7,8,9,10] or specific functionalizing [11,12,13,14]. Fe 3 O 4 nanoparticles have been already used as carriers for GEM in some in vitro approaches aiming to improve the drug release time [15], and efficiency [16,17].…”
Section: Introductionmentioning
confidence: 99%
“…In order to retain SPIONs, the magnetic force on a SPION (eq. 1) should overcome the force of the fluid flow derived from Stoke's Law [31][32][33][34]: = 6 (eq. 3).…”
Section: Discussionmentioning
confidence: 99%
“…Most probes use either immobilized antibodies, which capture viral particles through antigen-antibody interactions or DNA hybridization probes, which consist of a specific single-stranded nucleotide sequence complimentary to the target viral ssDNA or RNA, or ligand-functionalized NP via Au plasmon shift [12]. Depending on the probe architecture, binding could result in viral particle aggregation [13][14][15][16][17][18][19], collection on a 2D or 3D structure [20][21][22][23][24][25][26], or simply the creation of an individually "labelled" viral particle [27,28]. The ultimate detection method depends on the unique experiment design.…”
Section: Diffusionmentioning
confidence: 99%